参考文献/References:
[1] 曹志宇,张庆军,吴有军,等.早期三阴性乳腺癌保乳手术治疗的临床效果[J].解放军医学杂志,2020,45(9):986-989.
[2] HWANG S Y,PARK S,KWON Y.Recent therapeutic trends and promising targets in triple negative breast cancer[J].Pharmacol Ther,2019,199:30-57.
[3] 于晓函,骆成玉,刘宝胤.三阴性乳腺癌中AQP8的表达及其与血管生成、增殖和预后的相关性[J].临床和实验医学杂志,2019,18(22):2400-2404.
[4] 李开春,王雅杰.转移性三阴性乳腺癌临床研究现状[J].国际肿瘤学杂志,2020,47(3):169-173.
[5] JING M,SHUANG C,JINGXIA H,et al.Twist1 regulates vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma[J].Cancer Res,2018,78(15):4150-4162.
[6] ZHANG D,SUN B,ZHAO X,et al.Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer[J].Mol Cancer,2014,13(1):207.
[7] 周芳芳,陈冰.食管鳞癌组织中Slug、Vimentin、E-cadherin与血管生成拟态的表达及意义[J].山西医科大学学报,2017,48(2):52-56.
[8] 刘明,郭满,张浩,等.血管生成拟态及骨桥蛋白和基质金属蛋白酶2在三阴性乳腺癌组织中的表达及意义[J].新乡医学院学报,2019,36(4):345-349.
[9] ANDONEGUI-ELGUERA M A,ALFARO-MORA Y,CCERES-GUTIRREZ R,et al.An overview of vasculogenic mimicry in breast cancer[J].Front Oncol,2020,10:220.
[10] 胡保全,胡春艳,姜军,等.转录因子Twist在乳腺癌中的作用及研究进展[J].中华乳腺病杂志:电子版,2016,10(4):239-242.DOI:10.3877/cma.j.issn.1674-0807.2016.04.010.
[11] GOOSSENS S,VANDAMME N,VAN VLIERBERGHE P,et al.EMT transcription factors in cancer development re-evaluated:beyond EMT and MET[J].Biochim Biophys Acta Rev Cancer,2017,1868(2):584-591.
[12] TANG H,MASSI D,HEMMINGS B A,et al.AKT-ions with a TWIST between EMT and MET[J].Oncotarget,2015,7(38):62767-62777.
[13] LIANG W,SONG S,XU Y,et al.Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231[J].Mol Med Rep,2018,17(5):6711-6716.
[14] WAY T D,HUANG J T,CHOU C H,et al.Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways[J].Eur J Cancer,2014,50(2):366-378.
[15] TAO W,SUN W,ZHU H,et al.Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis[J].Biochem Biophys Res Commun,2018,504(4):629-634.
相似文献/References:
[1]路 娜,古吉敏,闵志波.肿瘤间质比在三阴性乳腺癌患者预后评估中的价值[J].新乡医学院学报,2017,34(12):1089.[doi:10.7683/xxyxyxb.2017.12.011]
LU Na,GU Ji-min,MIN Zhi-bo.Value of tumor-stroma ratio in evaluating the prognosis of patients with triple-negative breast cancer[J].Journal of Xinxiang Medical University,2017,34(5):1089.[doi:10.7683/xxyxyxb.2017.12.011]
[2]刘 明,郭 满,张 浩,等.血管生成拟态及骨桥蛋白和基质金属蛋白酶2在三阴性乳腺癌组织中的表达及意义[J].新乡医学院学报,2019,36(4):345.[doi:10.7683/xxyxyxb.2019.04.011]
LIU Ming,GUO Man,ZHANG Hao,et al.Expression and significance of vasculogenic mimicry,osteopontin and matrix metalloproteinase-2 in triple-negative breast cancer[J].Journal of Xinxiang Medical University,2019,36(5):345.[doi:10.7683/xxyxyxb.2019.04.011]
[3]郭 满,翟晓建,张 浩,等.p38蛋白激酶信号通路对骨桥蛋白介导的三阴性乳腺癌细胞自噬、凋亡活性的影响[J].新乡医学院学报,2018,35(12):1058.[doi:10.7683/xxyxyxb.2018.12.004]
GUO Man,ZHAI Xiao-jian,ZHANG Hao,et al.Effect of p38 mitogen-activated protein kinase signaling pathway on autophagy and apoptosis activity of triple negative breast cancer cell mediated by osteopontin[J].Journal of Xinxiang Medical University,2018,35(5):1058.[doi:10.7683/xxyxyxb.2018.12.004]
[4]刘德总,杨颖涛.乳腺癌辅助治疗现状与展望[J].新乡医学院学报,2021,38(8):781.[doi:10.7683/xxyxyxb.2021.08.017]
[5]付朝红,刘丹娜,段方方,等.晚期三阴性乳腺癌核苷酸切除修复交叉互补基因1表达与化学治疗效果的关系[J].新乡医学院学报,2017,34(10):904.[doi:10.7683/xxyxyxb.2017.10.010]
FU Chao-hong,LIU Dan-na,DUAN Fang-fang,et al.Relationship between excision repair cross complementing gene 1 expression and chemotherapeutic efficacy in patients with advanced triple-negative breast cancer[J].Journal of Xinxiang Medical University,2017,34(5):904.[doi:10.7683/xxyxyxb.2017.10.010]
[6]朱方园,邵营波,陈 琦,等.长链非编码RNA前列腺癌相关转录本7对三阴性乳腺癌MDA-MB-436细胞增殖、迁移及侵袭的影响[J].新乡医学院学报,2022,39(8):701.[doi:10.7683/xxyxyxb.2022.08.001]
ZHU Fangyuan,SHAO Yingbo,CHEN Qi,et al.Effect of long non-coding RNA prostate cancer associated transcript 7 on proliferation,migration and invasion of triple-negative breast cancer MDA-MB-436 cells[J].Journal of Xinxiang Medical University,2022,39(5):701.[doi:10.7683/xxyxyxb.2022.08.001]